PATENT CLAIM ANALYSIS

Application Number: 15935070
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "085200"]

Abstract:
A method for treating cancer and/or preventing or reducing metastasis or treating angiogenesis related disorders comprising the step of administering IL-31 or peptide which is at least about 70%, homologous to the IL-31 sequence as set forth in SEQ ID No. 1.

Claim (Index 5):
The method of  claim 1 , wherein the cancer is hematological malignance selected from the group consisting of multiple myeloma, acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoblasic leukemia, chronic myeloid leukemia (CML) or mesothieloma.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 90.0
- Lexical Diversity: 1.15
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15608715', '15501028', '15867655', '14502757', '12186208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.774800599975603
- 35 USC 102 Novelty (BERT): 0.5153181914037211
- Combined Prediction Score: 0.7488523591184149
- Mean Citation Score: 287.16266400000006
- Max Citation Score: 300.26953
- Similarity Product: 197.56836392487168

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test